The Food and Drug Administration’s flagship internal AI tool, Elsa, is being integrated with the data platform so that staff can accomplish work more easily.
Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help agency staff in drug clinical evaluations and reviews.
Food and Drug Administration Director Martin Makary announced the agency-wide deployment of an artificial intelligence tool to handle the monotonous components of its scientific review process.
VA Undersecretary for Health Shereef Elnahal told Nextgov/FCW that the testing environment is “a check in the process” to ensure that AI tools comply with federal guidance on the use of emerging tech.
The Government Accountability Office said medical devices are not commonly hacked but still called them “a source of cybersecurity concern warranting significant attention.”
The Food and Drug Administration is accepting comments on its Data and Technology Strategic Plan, which outlines the agency’s goals to leverage AI in its analytical processes.
The Food and Drug Administration is set to launch new pilot projects that aim to improve data interoperability and analysis across the public health community.
Early results from federal workforce campaigns suggest that vaccine uptake could present challenges once availability for all age groups is no longer an obstacle.
Furtive exchanges, police interdiction, international charter flights: our acquisition reporter takes a look at why the market for personal protective equipment looks so wild.
With feds on furlough or working without pay face the prospect of a missed paycheck, President Trump signaled a long shutdown by cancelling his trip to the World Economic Forum in Davos on Jan. 22.
As the Trump administration aims to drive efficiency and accuracy and eliminate "low-value work," agencies are starting to think about what aspects of their operations lend themselves to automation.
The House Energy & Commerce Committee staff didn't wait for a report on FDA's cyber vulnerabilities to be completed to before it let the agency know there was a big potential problem.
The Food and Drug Administration wants input from manufacturers and others about when a software update to a medical device would require premarket notification.